Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Kohanbash

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Cellular & Molecular Immunology|December 23, 2025
C/EBPβ-induced alternative splicing of RCAN1 generates a potent TCR-T target in mesenchymal glioblastomaZujian Xiong, Qinglin Kong, Bhuvitha Chagantipati, et al.
Cancer Research Communications|July 10, 2023
Immuno-PET Imaging of CD69 Visualizes T-Cell Activation and Predicts Survival Following Immunotherapy in Murine GlioblastomaMichal Nisnboym, Sarah R Vincze, Zujian Xiong, et al.
Journal of Biomedical Optics|May 16, 2023
Intraoperative molecular imaging: 3rd biennial clinical trials updatePatrick Bou-Samra, Najib Muhammad, Austin Chang, et al.
Science Translational Medicine|March 19, 2025
The T cell receptor landscape of childhood brain tumorsItay Raphael, Zujian Xiong, Chaim T Sneiderman, et al.
Nature Cell Biology|February 27, 2023
A neurodevelopmental epigenetic programme mediated by SMARCD3-DAB1-Reelin signalling is hijacked to promote medulloblastoma metastasisHan Zou, Bradley Poore, Emily E Brown, et al.
Journal for Immunotherapy of Cancer|March 7, 2025
Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocolsTricia R Cottrell, Michael T Lotze, Alaa Ali, et al.
Cell Reports|June 13, 2026
MYCN drives pediatric glioma transformation from neural progenitors and creates distinct therapeutic vulnerabilitiesTaylor A Gatesman, Srinidhi Varadharajan, Brenden J Johnson, et al.
Nature Cancer|June 23, 2022
Author Correction: Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenomeBrian J Golbourn, Matthew E Halbert, Katharine Halligan, et al.
Nature Cancer|April 15, 2022
Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenomeBrian J Golbourn, Matthew E Halbert, Katharine Halligan, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Cellular & Molecular Immunology|December 23, 2025
C/EBPβ-induced alternative splicing of RCAN1 generates a potent TCR-T target in mesenchymal glioblastomaZujian Xiong, Qinglin Kong, Bhuvitha Chagantipati, et al.
Cancer Research Communications|July 10, 2023
Immuno-PET Imaging of CD69 Visualizes T-Cell Activation and Predicts Survival Following Immunotherapy in Murine GlioblastomaMichal Nisnboym, Sarah R Vincze, Zujian Xiong, et al.
Journal of Biomedical Optics|May 16, 2023
Intraoperative molecular imaging: 3rd biennial clinical trials updatePatrick Bou-Samra, Najib Muhammad, Austin Chang, et al.
Science Translational Medicine|March 19, 2025
The T cell receptor landscape of childhood brain tumorsItay Raphael, Zujian Xiong, Chaim T Sneiderman, et al.
Nature Cell Biology|February 27, 2023
A neurodevelopmental epigenetic programme mediated by SMARCD3-DAB1-Reelin signalling is hijacked to promote medulloblastoma metastasisHan Zou, Bradley Poore, Emily E Brown, et al.
Journal for Immunotherapy of Cancer|March 7, 2025
Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocolsTricia R Cottrell, Michael T Lotze, Alaa Ali, et al.
Cell Reports|June 13, 2026
MYCN drives pediatric glioma transformation from neural progenitors and creates distinct therapeutic vulnerabilitiesTaylor A Gatesman, Srinidhi Varadharajan, Brenden J Johnson, et al.
Nature Cancer|June 23, 2022
Author Correction: Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenomeBrian J Golbourn, Matthew E Halbert, Katharine Halligan, et al.
Nature Cancer|April 15, 2022
Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenomeBrian J Golbourn, Matthew E Halbert, Katharine Halligan, et al.
Pageof 9